
GSK3004774
CAS No. 2138814-32-9
GSK3004774( GSK 3004774 | GSK-3004774 )
Catalog No. M13412 CAS No. 2138814-32-9
GSK3004774 (GSK-3004774) is a potent, nonabsorbable, gastrointestinally-restricted agonist agonist of calcium-sensing receptor (CaSR) with pEC50 of 7.3.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 530 | Get Quote |
![]() ![]() |
50MG | 1782 | Get Quote |
![]() ![]() |
100MG | 2250 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameGSK3004774
-
NoteResearch use only, not for human use.
-
Brief DescriptionGSK3004774 (GSK-3004774) is a potent, nonabsorbable, gastrointestinally-restricted agonist agonist of calcium-sensing receptor (CaSR) with pEC50 of 7.3.
-
DescriptionGSK3004774 (GSK-3004774) is a potent, nonabsorbable, gastrointestinally-restricted agonist agonist of calcium-sensing receptor (CaSR) with pEC50 of 7.3; demonstrates low permeability and low portal drug concentrations and high luminal stability and high fecal drug recovery in vivo DMPK experiments.
-
In Vitro——
-
In Vivo——
-
SynonymsGSK 3004774 | GSK-3004774
-
PathwayGPCR/G Protein
-
TargetCaSR
-
RecptorCaSR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2138814-32-9
-
Formula Weight528.697
-
Molecular FormulaC32H40N4O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (189.15 mM)
-
SMILESCC(C1=CC=CC2=CC=CC=C21)NC3CCN(C3)C4=CC=C(C=C4)C(=O)NCCCN5CCC(CC5)C(=O)O
-
Chemical Name1-(3-(4-((S)-3-(((R)-1-(naphthalen-1-yl)ethyl)amino)pyrrolidin-1-yl)benzamido)propyl)piperidine-4-carboxylic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.? Sparks?SM,?et?al.?Bioorg?Med?Chem?Lett.?2017?Oct?15;27(20):4673-4677.
molnova catalog



related products
-
Strontium ranelate
A strontium(II) salt of ranelic acid that stimulates CaSR and leads to the differentiation of pre-osteoblast to osteoblast, increases the bone formation; also stimulates osteoblasts to secrete osteoprotegerin in inhibiting osteoclasts formed from pre-osteoclasts in relation to the RANKL system.
-
Cinacalcet
A calcimimetic agent that acts as an allosteric activator of CaSR.
-
Cinacalcet hydrochlo...
A calcimimetic agent that acts as an allosteric activator of CaSR.